Paaerez Leirós C, Sterin-Borda L, Cossio P, Borda E S
Centro de Estudios Farmacológicos y Botánicos (CEFYBO) (ex-CEFAPRIN), CONICET, Buenos Aires, Argentina.
Proc Soc Exp Biol Med. 1990 Dec;195(3):356-63. doi: 10.3181/00379727-195-43155.
Evidence is presented showing that in experimental autoimmune myocarditis, there are certain components in IgG fraction of the sera that bind to myocardium muscarinic cholinergic receptors. The autoimmune IgG simulated the biologic effect of cholinergic agonists because (i) it increased cGMP levels, (ii) it decreased cAMP stimulated levels, and (iii) it reduced heart contractility and diminished reactivity to exogenous acetylcholine. Autoimmune IgG inhibited the binding of specific muscarinic cholinergic radioligand to purified myocardial membranes behaving as noncompetitive inhibitors. The recognition appears to be organ specific because the autoimmune IgG did not bind to muscarinic cholinergic receptors of urinary bladder. The presence of antibodies against antigens expressed in an accessible form to antibody in living myocardial cells might be related to some of the immunopathologic mechanisms participating in the pathogenesis of the experimental autoimmune myocarditis.
有证据表明,在实验性自身免疫性心肌炎中,血清IgG组分中的某些成分可与心肌毒蕈碱胆碱能受体结合。自身免疫性IgG模拟了胆碱能激动剂的生物学效应,因为(i)它增加了cGMP水平,(ii)它降低了cAMP刺激的水平,并且(iii)它降低了心脏收缩力并减弱了对外源性乙酰胆碱的反应性。自身免疫性IgG抑制特异性毒蕈碱胆碱能放射性配体与纯化的心肌膜的结合,表现为非竞争性抑制剂。这种识别似乎具有器官特异性,因为自身免疫性IgG不与膀胱的毒蕈碱胆碱能受体结合。针对活心肌细胞中抗体可及形式表达的抗原的抗体的存在,可能与参与实验性自身免疫性心肌炎发病机制的一些免疫病理机制有关。